Navigation Links
JHP Pharmaceuticals to Produce Supplies of Biologic Drug Product for Late-Phase Clinical Trials
Date:4/17/2013

PARSIPPANY, N.J., April 17, 2013 /PRNewswire/ -- JHP Pharmaceuticals, a leading provider of global contract manufacturing services for sterile products has entered into an agreement with an undisclosed biotechnology company to produce clinical supplies of a biologic for late-phase clinical trials.

JHP's cGMP compliance history was a critical factor in the selection process. Stuart Hinchen , CEO stated, "Our record of cGMP compliance, driven by experienced Quality and Regulatory Teams continues to be one of the key reasons customers choose JHP. Additionally, both new and established customers recognize our approach to ongoing investment in people and facilities. As an example, last year we broke ground on a new $10 million, 40,000 sq. ft. laboratory that will house QC Chemistry and Method Transfer, Sterility Assurance and Stability. This type of investment allows us to focus on customer needs, which results in sustainable sales growth."

Hinchen noted, "Our use of disposable product contact equipment is another leading factor in the selection process. JHP's strategic use of disposables provides our customers with manufacturing process efficiencies that result in reduced cycle time."

JHP Pharmaceuticals' Rochester, Michigan facility has over 25 years' experience in contract manufacturing. Expertise in seamlessly progressing from clinical batch production to commercialization provides customers with continuity of supply and program efficiencies. A comprehensive suite of services including Regulatory, Analytical Methods Development, Package Engineering, Stability Testing and Validation also support contract manufacturing customers. JHP has successfully supported launches of several products in US and international markets and manufactures products for sale in 86 countries.

About JHP Pharmaceuticals, LLC
JHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile products including biologics, small molecule, controlled substances, vaccines, ophthalmics, otics and antibiotics for large and small pharmaceutical and biotech organizations.

JHP's sterile manufacturing facility, located in Rochester Michigan sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse. The production facility utilizes three high-speed filling lines, a clinical filling line and four lyophilizers. The site also includes separate facilities for chemistry, sterility testing, and analytical methods development.

JHP has the capability to manufacture small-scale clinical through large-scale commercial products. JHP employs more than 380 staff in the USA in its manufacturing, product development, regulatory, sales and marketing and corporate areas. For more information, please visit www.jhppharma.com.  

Contact: 

Dan Leone 
973.658.3559

Bill Conway
877.906.7556

jhpcontractservices@jhppharma.com                                                                           MK360


'/>"/>
SOURCE JHP Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
2. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
3. Avion Pharmaceuticals, LLC., announces further expansion of their Womens Health Sales Team
4. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
5. Valeant Pharmaceuticals To Announce 2013 First Quarter Results On May 2, 2013
6. RoundTable Healthcare Partners and Argon Medical Devices Complete Acquisition of Angiotech Pharmaceuticals Interventional Products Business
7. Kinex Pharmaceuticals Chief Scientific Officer, Dr. David Hangauer, named the American Cancer Societys 2013 Honoree for its Cuisine for a Cure event
8. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
9. Merrimack Pharmaceuticals Preclinical Research Shows MM-111 Restores Sensitivity To Chemotherapy And HER2-targeted Treatment In Gastric Cancer Model
10. Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device
11. Faruqi & Faruqi, LLP is Investigating Peregrine Pharmaceuticals Inc. on Behalf of its Shareholders - PPHM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):